- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04868734
Superficial Supportive Psychotherapy Model and Its Effect on Acute Coronary Syndrome Psycho-Neuro-Endocrine Studies
Development of a Superficial Supportive Psychotherapy Model and Its Effect on Acute Coronary Syndrome Patients Psycho-Neuro-Endocrine Studies
Hypothesis
- The supportive psychotherapy model can be structured and developed for the non-pharmacologic therapy of acute coroner syndrome patients in intensive cardiac care unit
- The development of the supportive psychotherapy model can provide an improvement in psychological function in the form of a reduction in symptoms of anxiety, depression, and an improvement in the quality of life of acute coroner syndrome patients during treatment at intensive cardiac care unit.
- Psycho-patho-mechanization of supportive psychotherapy model development in the improvement of psychosomatic function of acute coroner syndrome patients by assessing the improvement of serotonin, cortisol, and immunoglobulin-A levels, and,
- Development of the supportive psychotherapy model can provide improvement in somatic function in the form of decreased complications such as arrhythmias, pericarditis, chronic heart failure, shock and death of acute coronary syndrome patients during treatment.
- Psychosomatic improvements, namely anxiety, depression, and cardiac complications associated with levels of serotonin, cortisol, immunoglobulin-A and heart rate variability.
Research objectives 1.1 General Objectives: To develop non-pharmacologic psychotherapy as part of holistic therapy for acute coronary syndrome patients during their treatment at intensive cardiac care unit.
1.2 Specific Objectives:
- Develop a structured supportive psychotherapy model
- Proving the role of supportive psychotherapy in the improvement of psychological symptoms of anxiety, depression and quality of life in acute coronary syndrome patients during treatment.
- Proving the psycho-patho-mechanism intervention of the supportive psychotherapy model in improving psychosomatic function through the Hypothalamus-Pituitary-Adrenal pathway, namely by assessing the improvement in levels of serotonin, cortisol, immunoglobulin-A and heart rate variability
- Proving the role of supportive psychotherapy in the improvement of somatic symptoms of cardiac complications such as arrhythmias, pericarditis, chronic heart failure, shock and death in acute coronary syndrome patients during treatment.
- To prove the supportive psychotherapy model in psychosomatic improvement, namely anxiety, depression, and cardiac complications associated with improvements in levels of serotonin, cortisol, immunoglobulin-A and heart rate variability.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction Acute coronary syndrome will have a high impact on who feels it. Psycho-neuro-immunological imbalance will occur before and after the attack. To date, there is no evidence regarding the role of supportive psychotherapy as a non-medical treatment in acute coronary syndromes. The study will also measure cortisol, immunoglobulin-A, serotonin, and heart rate variability for objective comparisons between intervention and usual cardiac care.
Method This research is an operational research with a mixed method research design, namely exploratory sequential method with qualitative method research that precedes quantitative methods. This research is divided into two stages, namely the qualitative research stage by developing a model of supportive psychotherapy, followed by the stage of applying the model to clinical trials of acute coronary syndrome patients during treatment at intensive cardiac care unit.
Result Total subject is 80 subject. All will collect blood and saliva sample, heart rate variability. One arm will do intervention (supportive psychotherapy) and the others will do usual cardiac care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jakarta, Indonesia
- Dr Cipto Mangunkusumo Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older
- Patients diagnosed with ACS by cardiologists and have received standard management with or without PCI.
- The patient is willing to participate in the research
Exclusion Criteria:
- ACS patients who had acute complications related to ACS upon admission before the study started, such as the presence of CHF, arrhythmias, pericarditis, cardiogenic shock or death.
- Psychotic disorders (with delusions or psychosis)
- Not willing to take part in research
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supportive Psychotherapy
Supportive Psychotherapy do to subjects
|
Supportive Psychotherapy give to patient with Acute Coronary Syndrome
|
No Intervention: Casual Treatment
Do Casual Intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes Visual Analog Scale In Comfort Feeling after Superficial Supportive Psychotherapy Model on Acute Coronary Syndrome Patients
Time Frame: per subject will completed about 12 days. Supportive psychotherapy will do to intervention subject and all subject (wit and without intervention) will ask visual analog scale at day 1, day 5, and day 12.
|
Visual Analog Scale measurement (in numeric scale from 0 to 10)
|
per subject will completed about 12 days. Supportive psychotherapy will do to intervention subject and all subject (wit and without intervention) will ask visual analog scale at day 1, day 5, and day 12.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in blood serotonin levels after Superficial Supportive Psychotherapy Model on Acute Coronary Syndrome Patients
Time Frame: All subject will completed about 12 days. The blood sample will check at day 1, day 5, and day 12.
|
Serotonin level measurement (ng/dL)
|
All subject will completed about 12 days. The blood sample will check at day 1, day 5, and day 12.
|
Changes in saliva cortisol levels after Superficial Supportive Psychotherapy Model on Acute Coronary Syndrome Patients
Time Frame: All subject will completed about 12 days. The saliva sample will check at day 1, day 5, and day 12.
|
Cortisol level measurement (ng/dL)
|
All subject will completed about 12 days. The saliva sample will check at day 1, day 5, and day 12.
|
Changes in saliva immunoglobulin-A levels after Superficial Supportive Psychotherapy Model on Acute Coronary Syndrome Patients
Time Frame: All subject will completed about 12 days. The saliva sample will check at day 1, day 5, and day 12.
|
Immunoglobulin-A level measurement (ng/dL)
|
All subject will completed about 12 days. The saliva sample will check at day 1, day 5, and day 12.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hamzah Shatri, Indonesia University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-11-1478
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosomatic Disorder
-
Yonggui YuanNot yet recruitingWell-Being, Psychological | Psychosomatic; Disorder, Multiple
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany
-
Hannover Medical SchoolInstitut für Arzneimittelsicherheit in der Psychiatrie AMSP e.V.; Asklepios... and other collaboratorsUnknownDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany
-
University Hospital HeidelbergDeutsches Krankenhausinstitut; DGPPN; DGKJP; DGPM; Forum für Gesundheitswirtschaft...RecruitingPsychosomatic MedicineGermany
-
Center for Primary Care and Public Health (Unisante)...University of Lausanne Hospitals; Neuchâtel Psychiatry Centre (CNP)Not yet recruitingQuality of Life | Mental Health Issue | Collaboration | Psychosomatic Disorders | Doctor-Patient Relation | Depression/Anxiety | Patients Lived ExperiencesSwitzerland
-
Dr. Becker Hospital GroupCompletedMental Disorder | Psychosomatic DisorderGermany
-
Radboud University Medical CenterCompletedMedically Unexplained Symptoms | Psychosomatic TherapyNetherlands
-
Hannover Medical SchoolUnknownLung Transplantation | Psychosomatic Medicine
-
Central Institute of Mental Health, MannheimMunich Chess academyRecruitingChildren and Adolescents Inpatient in Psychiatric HospitalGermany
-
Far Eastern Memorial HospitalCompletedMenopausal SyndromesTaiwan
Clinical Trials on Supportive Psychotherapy
-
University Hospital FreiburgCompletedChronic Major Depressive DisorderGermany
-
Hopital MontfortThe Ottawa HospitalCompletedDepression | Parkinson's DiseaseCanada
-
Memorial Sloan Kettering Cancer CenterUniversity of Manitoba; National Cancer Institute (NCI); Visiting Nurse Service... and other collaboratorsCompleted
-
National Center for Complementary and Integrative...Completed
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
Memorial Sloan Kettering Cancer CenterFordham UniversityCompletedPalliative CareUnited States
-
Veterans BioMedical Research InstituteRutgers UniversityCompleted
-
Icahn School of Medicine at Mount SinaiU.S. Department of EducationCompleted
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
New York State Psychiatric InstituteCompleted